ES2258280T3 - Nueva proteina de union a fibrinogeno originada a partir de staphylococus coagulasa negativo. - Google Patents

Nueva proteina de union a fibrinogeno originada a partir de staphylococus coagulasa negativo.

Info

Publication number
ES2258280T3
ES2258280T3 ES97928617T ES97928617T ES2258280T3 ES 2258280 T3 ES2258280 T3 ES 2258280T3 ES 97928617 T ES97928617 T ES 97928617T ES 97928617 T ES97928617 T ES 97928617T ES 2258280 T3 ES2258280 T3 ES 2258280T3
Authority
ES
Spain
Prior art keywords
protein
baselineskip
fibrinogen
polypeptide
fibrinogen binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97928617T
Other languages
English (en)
Spanish (es)
Inventor
Bengt Guss
Martin Nilsson
Lars Frykberg
Jan-Ingmar Flock
Martin Lindberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biostapro AB
Original Assignee
Biostapro AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biostapro AB filed Critical Biostapro AB
Application granted granted Critical
Publication of ES2258280T3 publication Critical patent/ES2258280T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES97928617T 1996-06-20 1997-06-18 Nueva proteina de union a fibrinogeno originada a partir de staphylococus coagulasa negativo. Expired - Lifetime ES2258280T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602496 1996-06-20
SE9602496A SE9602496D0 (sv) 1996-06-20 1996-06-20 Method and means for producing a fibrinogen binding protein and its use in biotechnology

Publications (1)

Publication Number Publication Date
ES2258280T3 true ES2258280T3 (es) 2006-08-16

Family

ID=20403140

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97928617T Expired - Lifetime ES2258280T3 (es) 1996-06-20 1997-06-18 Nueva proteina de union a fibrinogeno originada a partir de staphylococus coagulasa negativo.

Country Status (10)

Country Link
US (2) US6733758B1 (fr)
EP (1) EP0922056B1 (fr)
JP (1) JP4173549B2 (fr)
AT (1) ATE316979T1 (fr)
AU (1) AU3282597A (fr)
CA (1) CA2294433A1 (fr)
DE (1) DE69735207T2 (fr)
ES (1) ES2258280T3 (fr)
SE (1) SE9602496D0 (fr)
WO (1) WO1997048727A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685943B1 (en) 1997-01-21 2004-02-03 The Texas A&M University System Fibronectin binding protein compositions and methods of use
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
EP2319931A1 (fr) * 1997-11-26 2011-05-11 Inhibitex, Inc. Proteines liant la matrice extracellulaire issues du staphilococcus aureus
US6692739B1 (en) * 1998-08-31 2004-02-17 Inhibitex, Inc. Staphylococcal immunotherapeutics via donor selection and donor stimulation
JP2002523474A (ja) * 1998-08-31 2002-07-30 インヒビテツクス,インコーポレイテツド ドナーの選択およびドナーの刺激によるブドウ球菌の免疫療法
BR9913340A (pt) * 1998-08-31 2001-11-06 Inhibitex Inc Composição, vacina, e, processos de gerar uma resposta imune, e de inibir a colonização microbiana em um animal
AU772547B2 (en) * 1998-08-31 2004-04-29 Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The Polypeptides and polynucleotides from coagulase-negative staphylococci
US6703025B1 (en) 1998-08-31 2004-03-09 Inhibitex, Inc. Multicomponent vaccines
US20040038327A1 (en) * 1999-08-31 2004-02-26 Foster Timothy J. Antibodies to polypeptides from coagulase-negative staphylococci
EP2339344A1 (fr) 2001-06-15 2011-06-29 Inhibitex, Inc. Anticorps monoclonaux et polyclonaux à réaction croisée qui reconnaissent des protéines de surface de staphylocoques à coagulase négative et de staphylocoques dores
WO2003076470A1 (fr) * 2002-03-05 2003-09-18 Inhibitex, Inc. Anticorps monoclonaux et polyclonaux reconnaissant des proteines staphylocoques a coagulase negative
BRPI0408167B1 (pt) 2003-03-07 2014-10-21 Wyeth Corp Conjugados de polissacarídeo-proteína veículo adesina da superfície estafilocócica para imunização contra infecções nosocomiais
US20080095777A1 (en) 2004-09-22 2008-04-24 Glaxosmithkline Biologicals S.A. Immunogenic Composition for Use in Vaccination Against Staphylococcei
JP2009531387A (ja) 2006-03-30 2009-09-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
WO2007127339A2 (fr) * 2006-04-26 2007-11-08 Tyco Healthcare Group Lp Dispositif de microporation multi-étagée
MX2012000044A (es) 2009-06-22 2012-01-30 Wyeth Llc Composiciones inmunogenicas de antigenos de staphylococcus aureus.
EP2454284B1 (fr) 2009-07-15 2018-04-11 AIMM Therapeutics B.V. Composés de liaison spécifiques de bactéries à gram positif
GB0913680D0 (en) 2009-08-05 2009-09-16 Glaxosmithkline Biolog Sa Immunogenic composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3583987D1 (de) 1984-11-06 1991-10-10 Thomae Gmbh Dr K Antibiotisches polypeptid, verfahren zu seiner herstellung und seine verwendung.
ES2059645T3 (es) * 1988-07-15 1994-11-16 Thomae Gmbh Dr K Procedimiento para la obtencion, el aislamiento y la purificacion de epidermina.
US5055455A (en) * 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US5571511A (en) * 1990-10-22 1996-11-05 The U.S. Government Broadly reactive opsonic antibodies that react with common staphylococcal antigens
AU4837193A (en) 1992-09-21 1994-04-12 Alfa-Laval Agri International Aktiebolag Fibrinogen binding protein
IL109410A0 (en) * 1993-04-30 1994-07-31 Ell Lilly & Company Fema gene of staphylococcus epidermidis, fema protein, and vectors and microorganisms comprising the fema gene
US6107068A (en) * 1995-12-22 2000-08-22 The University Of British Columbia Coenzyme A disulfide reductase, and inhibitors thereof useful as antimicrobial agents

Also Published As

Publication number Publication date
SE9602496D0 (sv) 1996-06-20
CA2294433A1 (fr) 1997-12-24
JP2001503609A (ja) 2001-03-21
US20040209326A1 (en) 2004-10-21
EP0922056A1 (fr) 1999-06-16
JP4173549B2 (ja) 2008-10-29
DE69735207T2 (de) 2006-11-02
DE69735207D1 (de) 2006-04-13
US6733758B1 (en) 2004-05-11
WO1997048727A1 (fr) 1997-12-24
AU3282597A (en) 1998-01-07
EP0922056B1 (fr) 2006-02-01
ATE316979T1 (de) 2006-02-15
US7160990B2 (en) 2007-01-09

Similar Documents

Publication Publication Date Title
ES2258280T3 (es) Nueva proteina de union a fibrinogeno originada a partir de staphylococus coagulasa negativo.
KR100871330B1 (ko) 응고효소 음성 포도상구균 유래의 폴리펩타이드 및폴리뉴클레오타이드
KR101505496B1 (ko) 스태필로코쿠스에 대한 예방접종에 사용하기 위한 면역원성 조성물
AU752794B2 (en) Treatment and diagnosis of staphylococcal infections
Sun et al. Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding
US20160074497A1 (en) Staphylococcus live cell vaccines
ES2285709T3 (es) Fragmentos de polipeptidos capaces de competir con el antigeno i/ii de streptococcus mutans.
ES2238080T3 (es) Tratamiento y diagnostico de infecciones por cocos gram positivos.
US20040038327A1 (en) Antibodies to polypeptides from coagulase-negative staphylococci
Todryk et al. Induction of immune responses to functional determinants of a cell surface streptococcal antigen.
US20040014178A1 (en) Von willebrand factor-binding proteins from staphylococci
JP2000500326A (ja) フィブロネクチン結合タンパク質b化合物
CA2324981A1 (fr) Peptides
JPH10290693A (ja) 新規フィブロネクチン結合蛋白化合物
AU2004203421A1 (en) Polypeptides and polynucleotides from coagulase-negative staphylococci
JP2002528112A (ja) タンパク質